2022 Controlled Substances Intravenous Solutions 
Beckers Hospital Review
AUGUST 13, 2025
He led critical logistics initiatives, including the creation of a supply assurance dashboard during a national intravenous solution shortage, the development of par optimization tools and the establishment of a direct distribution model for more than 50 offsite locations. Kevin Gordon. Thomas Lubotsky.
FDA Law Blog: Biosimilars
MAY 16, 2024
Houck — Employee diversion of controlled substances from hospitals has been an issue since at least 1986 when I became a diversion investigator with the Drug Enforcement Administration (“DEA”). DEA alleged that UMHS failed to maintain complete and accurate records and failed to timely notify DEA of controlled substance thefts.
Expert insights. Personalized for you.
Let's personalize your content